Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246012
Status:
COMPLETED
Last Update Posted:
2013-08-19
First Post:
2005-10-28
Brief Title:
A Safety and Efficacy Study of Intetumumab Alone and in Combination With Dacarbazine in Participants With Stage 4 Melanoma
Sponsor:
Centocor Inc
Organization:
Centocor Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-28
First Submit QC Date:
October 28 2005
Study First Post Date:
2005-10-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-08-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-17
Last Update Post Date:
2013-08-19
Last Update Post Date Type:
ESTIMATED